Clinical Trial

A Study of NHL907 in Healthy Adult Participants

Name: A Study of NHL907 in Healthy Adult Participants — clinical trial record (NCT07580924)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 1

View on ClinicalTrials.gov →

Summary

The goal of this study is to evaluate the safety, tolerability and pharmacokinetics of NHL907 when administered as multiple oral doses in healthy adult participants.

Protocol Amendment History 1 change

critical Recruitment opened 2026-06-11

Trial Details

NCT Number	NCT07580924
Lead Sponsor	NeuHyll AUS Pty Ltd Collaborators: NeuHyll Therapeutics Inc
Conditions	Healthy Adult Participants
Enrollment	64 participants
Start Date	2026-05-12
Primary Completion	2027-02 (estimated)
Study Completion	2027-04 (estimated)
Updated on ClinicalTrials.gov	2026-06-10